Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

被引:0
作者
Shwetha Nanjundaiah
Hariharakrishnan Chidambaram
Madhura Chandrashekar
Subashchandrabose Chinnathambi
机构
[1] CSIR-National Chemical Laboratory (CSIR-NCL),Neurobiology Group, Division of Biochemical Sciences
[2] Academy of Scientific and Innovative Research (AcSIR),School of Biomedical Engineering and Sciences
[3] MIT University,undefined
来源
Cellular and Molecular Neurobiology | 2021年 / 41卷
关键词
Alzheimer’s disease; Amyloid-β protein; Tau hyperphosphorylation; Cholesterol; Microglia;
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol, a principal constituent of the cell membrane, plays a crucial role in the brain by regulating the synaptic transmission, neuronal signaling, as well as neurodegenerative diseases. Defects in the cholesterol trafficking are associated with enhanced generation of hyperphosphorylated Tau and Amyloid-β protein. Tau, a major microtubule-associated protein in the brain, is the key regulator of the mature neuron. Abnormally hyperphosphorylated Tau hampers the major functions related to microtubule assembly by promoting neurofibrillary tangles of paired helical filaments, twisted ribbons, and straight filaments. The observed pathological changes due to impaired cholesterol and Tau protein accumulation cause Alzheimer's disease. Thus, in order to regulate the pathogenesis of Alzheimer's disease, regulation of cholesterol metabolism, as well as Tau phosphorylation, is essential. The current review provides an overview of (1) cholesterol synthesis in the brain, neurons, astrocytes, and microglia; (2) the mechanism involved in modulating cholesterol concentration between the astrocytes and brain; (3) major mechanisms involved in the hyperphosphorylation of Tau and amyloid-β protein; and (4) microglial involvement in its regulation. Thus, the answering key questions will provide an in-depth information on microglia involvement in managing the pathogenesis of cholesterol-modulated hyperphosphorylated Tau protein.
引用
收藏
页码:651 / 668
页数:17
相关论文
共 630 条
  • [1] Abraha A(2000)C-terminal inhibition of tau assembly in vitro and in Alzheimer’s disease J Cell Sci 113 3737-3745
  • [2] Ghoshal N(2010)Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus Brain Res 1318 167-177
  • [3] Gamblin TC(2004)Promotion of hyperphosphorylation by frontotemporal dementia tau mutations J Biol Chem 279 34873-34881
  • [4] Akram A(1994)Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease Proc Natl Acad Sci USA 91 5562-5566
  • [5] Schmeidler J(2005)Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein Proc Natl Acad Sci USA 102 13461-13466
  • [6] Katsel P(1990)Rates of cholesterol, ubiquinone, dolichol and dolichyl-P biosynthesis in rat brain slices FEBS Lett 269 15-18
  • [7] del Alonso AC(2005)Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases Biochim Biophys Acta 1739 91-103
  • [8] Mederlyova A(2016)Tau and tauopathies Brain Res Bull 126 238-292
  • [9] Novak M(2004)APOE genotype effects on Alzheimer’s disease onset and epidemiology J Mol Neurosci 23 157-165
  • [10] Alonso AC(2016)Tau structures Front Aging Neurosci 8 262-14631